Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unraveling the genetics of inhibitors in hemophilia.
Gouw SC, Fijnvandraat K. Gouw SC, et al. Among authors: fijnvandraat k. Blood. 2013 Feb 21;121(8):1250-1. doi: 10.1182/blood-2012-12-472647. Blood. 2013. PMID: 23429985 Free article.
Hemophilia management: Huge impact of a tiny difference.
Kloosterman F, Zwagemaker AF, Abdi A, Gouw S, Castaman G, Fijnvandraat K. Kloosterman F, et al. Among authors: fijnvandraat k. Res Pract Thromb Haemost. 2020 Feb 28;4(3):377-385. doi: 10.1002/rth2.12314. eCollection 2020 Mar. Res Pract Thromb Haemost. 2020. PMID: 32211572 Free PMC article.
The factor VIII treatment history of non-severe hemophilia A.
Abdi A, Kloosterman FR, Eckhardt CL, Male C, Castaman G, Fischer K, Beckers EAM, Kruip MJHA, Peerlinck K, Mancuso ME, Santoro C, Hay CR, Platokouki H, van der Bom JG, Gouw SC, Fijnvandraat K, Hart DP; INSIGHT Study Group. Abdi A, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2020 Dec;18(12):3203-3210. doi: 10.1111/jth.15076. Epub 2020 Sep 28. J Thromb Haemost. 2020. PMID: 32877570 Free PMC article.
ADAMTS-13 and bleeding phenotype in von Willebrand disease.
Boender J, Nederlof A, Meijer K, Mauser-Bunschoten EP, Cnossen MH, Fijnvandraat K, van der Bom JG, de Meris J, Laros-van Gorkom BAP, van Galen KPM, Eikenboom J, de Maat MPM, Leebeek FWG; WiN Study Group. Boender J, et al. Among authors: fijnvandraat k. Res Pract Thromb Haemost. 2020 Oct 31;4(8):1331-1339. doi: 10.1002/rth2.12442. eCollection 2020 Nov. Res Pract Thromb Haemost. 2020. PMID: 33313472 Free PMC article.
Treatment-related risk factors for inhibitor development in non-severe hemophilia A after 50 cumulative exposure days: A case-control study.
Abdi A, Eckhardt CL, van Velzen AS, Vuong C, Coppens M, Castaman G, Hart DP, Hermans C, Laros-van Gorkom B, Leebeek FWG, Mancuso ME, Mazzucconi MG, McRae S, Oldenburg J, Male C, van der Bom JG, Fijnvandraat K, Gouw SC; INSIGHT Study Group. Abdi A, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2021 Sep;19(9):2171-2181. doi: 10.1111/jth.15419. Epub 2021 Jul 19. J Thromb Haemost. 2021. PMID: 34107158 Free PMC article.
222 results